Book Review: Nancy E. Marion,Drug Policy and the Criminal Justice System

Akers R. L. (1985). Deviant behavior: A social learning approach (3rd ed.). Belmont, CA: Wadsworth.

Alderks C. E. (2017). Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 (Update). Retrieved from https://www.samhsa.gov/data/sites/default/files/report_3192/ShortReport-3192.pdf

Bureau of Justice Statistics. (2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007-2009. Retrieved from https://www.bjs.gov/content/pub/pdf/dudaspji0709.pdf

Center for Disease Control and Prevention. (2018). Drug overdose deaths in the United States, 1999–2016. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db294.htm

Ford J. A. Arrastia M. C. (2008). Pill-poppers and dopers: A comparison of non-medical prescription drug use and illicit/street drug use among college students. Addictive Behaviors, 33, 934-941.

Gray J. P. (2012). Why our drug laws have failed and what we can do about it: A judicial indictment of the war on drugs (2nd ed.). Philadelphia, PA: Temple University Press.

Hadley M. (2019). Deflecting opioid suffers from the justice system “can save lives,” experts say. Retrieved from https://thecrimereport.org/2019/02/26/deflecting-opioid-sufferers-from-the-justice-system-can-save-lives-experts-say/

Hanson C. L. Burton S. H. Giraud-Carrier C. West J. H. Barnes M. D. Hansen B. (2013). Tweaking and tweeting: Exploring twitter for nonmedical use of a psychostimulant drug (Adderall) among college students. Journal of Medical Internet Research, 15(4), e62.

Krupitsky E. M. Zvartau E. E. Masalov D. V. Tsoy M. V. Burakov A. M. Egorova V. Y. … Verbitskaya E. V. (2006). Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. Journal of Substance Abuse Treatment, 31, 319-328.

Lilly J. R. Cullen F. T. Ball R. A. (2015). Criminological theory: Context and consequences (6th ed.). Thousand Oaks, CA: Sage.

Ling W. (2009). Buprenorphine for opioid dependence. Expert Review of Neurotherapeutics, 9, 609-616.

Marion N. E. Hill J. B. (2018). More on legalizing marijuana: Ongoing shifts in American politics. Durham, NC: Carolina Academic Press.

Minozzi S. Amato L. Vecchi S. Davoli M. Kirchmayer U. Verster A. (2011). Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews, 4, 1-47.

Mosher C. J. Akins S. (2013). Drugs and drug policy: The control of consciousness alteration (2nd ed.). Thousand Oaks, CA: Sage.

Mumola C. J. Karberg J. C. (2006). Drug use and dependence, state and federal prisoners, 2004. Retrieved from https://www.bjs.gov/content/pub/pdf/dudsfp04.pdf

National Institute on Drug Abuse. (2018). What is the scope of heroin use in the United States? Retrieved from https://www.drugabuse.gov/publications/research-reports/heroin/scope-heroin-use-in-united-states

Nunes E. V. Rothenberg J. L. Sullivan M. A. Carpenter K. M. Kleber H. D. (2006). Behavioral therapy to augment oral naltrexone for opioid dependence: A ceiling on effectiveness? The American Journal of Drug and Alcohol Abuse, 32, 503-517.

Substance Abuse and Mental Health Services Administration. (2019). Buprenorphine. Retrieved from https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine

Sutherland E. (1947). Principles of criminology (4th ed.). Philadelphia, PA: Lippincott.

Tucker T. Ritter A. Maher C. Jackson H. (2004). A randomized control trial of group counseling in a naltrexone treatment program. Journal of Substance Abuse Treatment, 27, 277-288.

World Health Organization. (2017). Introduction to drug misuse. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK53217/

World Health Organization. (2019). Substance Abuse. Retrieved from https://www.who.int/topics/substance_abuse/en/